These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21422925)

  • 1. Has the incidence of end-stage renal disease in the USA and other countries stabilized?
    Eggers PW
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):241-5. PubMed ID: 21422925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic CKD/ESRD 2010: a progress report?
    Williams ME
    Semin Dial; 2010; 23(2):129-33. PubMed ID: 20210917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal disease in Indonesia: treatment development.
    Prodjosudjadi W; Suhardjono A
    Ethn Dis; 2009; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
    Couchoud C; Guihenneuc C; Bayer F; Lemaitre V; Brunet P; Stengel B;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2312-22. PubMed ID: 22121236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease in Canada: prevalence projections to 2005.
    Schaubel DE; Morrison HI; Desmeules M; Parsons DA; Fenton SS
    CMAJ; 1999 Jun; 160(11):1557-63. PubMed ID: 10373996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of elderly patients with diabetes and end-stage renal disease.
    Goldfarb-Rumyantzev AS; Rout P
    Semin Dial; 2010; 23(2):185-90. PubMed ID: 20374551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance dialysis population dynamics: current trends and long-term implications.
    Lysaght MJ
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S37-40. PubMed ID: 11792760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends of incident dialysis patients in Tunisia between 1992 and 2001.
    Counil E; Cherni N; Kharrat M; Achour A; Trimech H
    Am J Kidney Dis; 2008 Mar; 51(3):463-70. PubMed ID: 18295062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global variation in renal replacement therapy for end-stage renal disease.
    Caskey FJ; Kramer A; Elliott RF; Stel VS; Covic A; Cusumano A; Geue C; Macleod AM; Zwinderman AH; Stengel B; Jager KJ
    Nephrol Dial Transplant; 2011 Aug; 26(8):2604-10. PubMed ID: 21245131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the epidemiology of focal segmental glomerulosclerosis.
    Kitiyakara C; Kopp JB; Eggers P
    Semin Nephrol; 2003 Mar; 23(2):172-82. PubMed ID: 12704577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.
    Port FK
    Kidney Int Suppl; 1995 Aug; 50():S3-6. PubMed ID: 8544432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-stage renal disease and its treatment in Latin America in the twenty-first century.
    Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
    Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.
    Kitiyakara C; Eggers P; Kopp JB
    Am J Kidney Dis; 2004 Nov; 44(5):815-25. PubMed ID: 15492947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and prevention of end stage renal disease in uruguay.
    Mazzuchi N; Schwedt E; Solá L; González C; Ferreiro A
    Ren Fail; 2006; 28(8):617-25. PubMed ID: 17162418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in end-stage renal disease care in South America.
    Lugon JR; Strogoff de Matos JP
    Clin Nephrol; 2010 Nov; 74 Suppl 1():S66-71. PubMed ID: 20979967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, prevalence, and treatment of end-stage renal disease in the Middle East.
    Abboud O
    Ethn Dis; 2006; 16(2 Suppl 2):S2-2-4. PubMed ID: 16774000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.